Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Georg et al

In addition to the Figures published in the original article and associated supplemental Figures, the attached files contain the following information:
Mendeley Data 1-4
• Members of the PA-COVID-19 Study group
• Mendeley Data 1: a reanalysis of a published scRNA-seq data set of bronchoalveolar lavage (BAL) samples from COVID-19 patients and patients with non-COVID-19 pneumonia (Wauters et al., 2021) to investigate T cells and their phenotypes from the lung .
• Mendeley Data 2: Gating strategy and represantative plots of Figure S1
• Mendeley Data 3: Gating strategy and represantative plots of Figure 5D
• Mendeley Data 4: Gating strategy Firgures 5F/G/H

Supplementary Tables 1-6
• Supplementary Table 1: Cohort details related to Figures 1-6.
• Supplementary Table 2: Gene lists for the signatures “Response to Type I Interferon” , “Defense Response to virus” and “Cytotoxicity” used for GSEA, related to Figure 2 and Figure S3.
• Supplementary Table 3: Antibody panel “MCFC cohort 2” , related to Figure S1 and STAR Methods
• Supplementary Table 4: Antibody panel “degranulation assays” , related to Figures 3C-E.
• Supplementary Table 5: Antibody panel for “C3a binding capacity” , related to Figure 5D.
• Supplementary Table 6: Antibody panel “SARS-CoV-2 reactivity” , related to Figure 3F.

Gene list Annotation for scRNA sequencing